Skip to main content

Table 2 The short-term efficacy of Group D1 and Group D2

From: Current status of neoadjuvant therapy for locally advanced rectal cancer in Wuhan Union Hospital Cancer Center

 

Group D1 (n = 37)

Group D2 (n = 61)

P value

No. of patients

%

No. of patients

%

 

pCR

8

21.6

30

49.2

0.007

T-stage decreased

22

59.5

49

80.3

0.025

N-stage decreased

26

70.3

46

75.4

0.576

R0 resection

0

100.0

1

1.6

-

  1. Abbreviations: pathological complete response